Your browser doesn't support javascript.
loading
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial.
Peyrin-Biroulet, Laurent; Hart, Ailsa; Bossuyt, Peter; Long, Millie; Allez, Matthieu; Juillerat, Pascal; Armuzzi, Alessandro; Loftus, Edward V; Ostad-Saffari, Elham; Scalori, Astrid; Oh, Young S; Tole, Swati; Chai, Akiko; Pulley, Jennifer; Lacey, Stuart; Sandborn, William J.
Afiliación
  • Peyrin-Biroulet L; Université Centre Hospitalier Régional et Universitaire de Nancy, Vandoeuvre-lès-Nancy, France.
  • Hart A; St Mark's Academic Institute, London, UK.
  • Bossuyt P; Imelda GI Clinical Research Centre, Imelda General Hospital, Bonheiden, Belgium.
  • Long M; Division of Gastroenterology and Hepatology, School of Medicine, The University of North Carolina, Chapel Hill, NC, USA.
  • Allez M; Department of Gastroenterology Hôpital Saint-Louis, AP-HP, INSERM U1160, University Denis Diderot, Paris, France.
  • Juillerat P; Inselspital, Gastroenterology, Clinic for Visceral Surgery and Medicine, University Hospital of Bern, Bern, Switzerland.
  • Armuzzi A; Fondazione Policlinico Universitario Agostino Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico, Università Cattolica, Dipartimento di Scienze Mediche e Chirurgiche, Policlinico Agostino Gemelli, Rome, Italy.
  • Loftus EV; Gastroenterology and Hepatology, Mayo Clinic School of Medicine, Rochester, MN, USA.
  • Ostad-Saffari E; Roche Products Limited, Welwyn Garden City, UK.
  • Scalori A; Roche Products Limited, Welwyn Garden City, UK.
  • Oh YS; Genentech, South San Francisco, CA, USA.
  • Tole S; Genentech, South San Francisco, CA, USA.
  • Chai A; Genentech, South San Francisco, CA, USA.
  • Pulley J; Roche Products Limited, Welwyn Garden City, UK.
  • Lacey S; Roche Products Limited, Welwyn Garden City, UK.
  • Sandborn WJ; University of California San Diego, La Jolla, CA, USA. Electronic address: wsandborn@health.ucsd.edu.
Lancet Gastroenterol Hepatol ; 7(2): 128-140, 2022 02.
Article en En | MEDLINE | ID: mdl-34798039
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fármacos Gastrointestinales / Colitis Ulcerosa / Anticuerpos Monoclonales Humanizados / Inhibidores del Factor de Necrosis Tumoral Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: America do norte / America do sul / Asia / Europa / Oceania Idioma: En Revista: Lancet Gastroenterol Hepatol Año: 2022 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fármacos Gastrointestinales / Colitis Ulcerosa / Anticuerpos Monoclonales Humanizados / Inhibidores del Factor de Necrosis Tumoral Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: America do norte / America do sul / Asia / Europa / Oceania Idioma: En Revista: Lancet Gastroenterol Hepatol Año: 2022 Tipo del documento: Article País de afiliación: Francia